HDAX Therapeutics’ co-founder announced winner of 2023 Gold Leaf Awards for Next Generation Leadership

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Nabanita Nawar, co-founder/CEO of HDAX Therapeutics, is the winner of BIOTECanada’s Gold Leaf Award for Next Generation Leadership. The awards recognize the remarkable individuals and companies who have made significant contributions to the biotech industry in Canada. The 2023 Gold Leaf Awards ceremony will be held on September 27 at the National Arts Centre in Ottawa during Global Biotech Week (September 24 – 30).

HDAX Therapeutics is a drug discovery start-up developing targeted therapeutics platform for the safe and efficacious treatment of HDAC-driven pathologies such as neuropathies and neurodegenerative disorders.

HDAX Therapeutics is an OBIO® member, an alumnus of the BDSP™ and WiHI programs and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Retispec’s eye test tool could catch Alzheimer’s signs years earlier
Next

Epineuron announces enrollment of its first patient in REGAIN™